Location History:
- Aston, PA (US) (2004)
- Collegeville, PA (US) (2005)
Company Filing History:
Years Active: 2004-2005
Title: **Innovative Breakthroughs by Inventor Baoqing Li in Neurological Disorders**
Introduction
Baoqing Li, based in Collegeville, PA, is a prominent inventor known for his significant contributions to the field of pharmacology with a focus on neurological disorders. Holding three patents, Li's innovative work centers around compounds that can potentially treat disorders associated with excessive activation of non-NMDA ionotropic excitatory amino acid (EAA) receptors.
Latest Patents
Li's latest patents highlight his profound understanding of complex biochemical interactions.
1. **Sulfur Containing Dihydrophthalazine Antagonists of Excitatory Amino Acid Receptors**: This patent describes substituted dihydrophthalazine sulfur-containing compositions that act as antagonists for non-NMDA EAA receptors. The potential therapeutic applications of these compositions encompass treatment for disorders such as stroke, ischemia, and epilepsy. The compounds can be administered through both oral and parenteral routes, making them versatile for various therapeutic needs.
2. **5H-2,3-Benzodiazepine Antagonists of Excitatory Amino Acid Receptors**: In this patent, Li introduces substituted benzodiazepine compositions that function similarly as antagonists for the non-NMDA EAA receptors. These compounds are particularly useful in treating disorders linked with dysregulated non-NMDA receptor activity. Their therapeutic implications also extend to neuropsychopharmacological disorders, with multiple administration options available for enhanced patient care.
Career Highlights
Throughout his career, Li has demonstrated a remarkable ability to innovate in the pharmacological realm. His latest patents exemplify his commitment to developing solutions that address critical health issues. By focusing on the medical implications of his inventions, he has positioned himself as a vital contributor to ongoing research and treatment advancements in neurological disorders.
Collaborations
Baoqing Li collaborates closely with colleagues such as Xue-Feng Pei and Maria-Luisa Maccecchini at Transgenomic, Inc. These partnerships have fostered a collaborative environment that promotes the development of groundbreaking therapeutic options, amplifying the impact of their collective work on patient care.
Conclusion
In summary, Baoqing Li stands out as an influential inventor in the field of pharmacology, particularly concerning innovative treatments for neurological disorders. With three patents to his name, his work brings hope for effective interventions in the medical community, showcasing the significance of collaboration and innovation in addressing complex health challenges.